phenylalanine has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, YM; Dzeja, PD; Nemutlu, E; Terzic, A; Xu, YZ; Zhang, S; Zhong, L | 1 |
| Barbier, S; Henry, JP; Jeng, AY; Monteil, C; Mulder, P; Renet, S; Thuillez, C | 1 |
2 other study(ies) available for phenylalanine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure.
Topics: Aged; Cardiac Resynchronization Therapy; Catheter Ablation; Energy Metabolism; Female; Gas Chromatography-Mass Spectrometry; Glucose; Heart Failure; Humans; Isoleucine; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Myocardium; Phenylalanine; Predictive Value of Tests; Prognosis; Prospective Studies; Tachycardia, Supraventricular; Ventricular Dysfunction, Left; Ventricular Remodeling | 2015 |
Sustained improvement of cardiac function and prevention of cardiac remodeling after long-term dual ECE-NEP inhibition in rats with congestive heart failure.
Topics: Animals; Aspartic Acid Endopeptidases; Blood Pressure; Cardiac Output; Endothelin-Converting Enzymes; Heart Failure; Heart Rate; Male; Metalloendopeptidases; Neprilysin; Organophosphonates; Phenylalanine; Rats; Rats, Wistar; Tetrazoles; Ventricular Remodeling | 2004 |